Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development (Nature Immunology, (2019), 20, 11, (1409-1413), 10.1038/s41590-019-0503-1)

1. Mastellos, D.C.
2. Blom, A.M.
3. Connolly, E.S.
4. Daha, M.R.
5. Geisbrecht, B.V.
6. Ghebrehiwet, B.
7. Gros, P.
8. Hajishengallis, G.
9. Holers, V.M.
10. Huber-Lang, M.
11. Kinoshita, T.
12. Mollnes, T.E.
13. Montgomery, R.A.
14. Morgan, B.P.
15. Nilsson, B.
16. Pio, R.
17. Ricklin, D.
18. Risitano, A.M.
19. Taylor, R.P.
20. Mantovani, A.
21. Ioannidis, J.P.A.
22. Lambris, J.D.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1038/S41590-019-0531-X GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus